Literature DB >> 10669448

Regular review: tumour markers in malignancies.

A Lindblom1, A Liljegren.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10669448      PMCID： PMC1117546          DOI： 10.1136/bmj.320.7232.424

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  34 in total

Review 1.  AFP isoforms and their clinical significance (overview).

Authors:  R Lamerz
Journal:  Anticancer Res       Date:  1997 Jul-Aug       Impact factor: 2.480

2.  Malignant melanoma of the soft parts (clear-cell sarcoma): confirmation of EWS and ATF-1 gene fusion caused by a t(12;22) translocation.

Authors:  F Speleman; O Delattre; M Peter; E Hauben; N Van Roy; E Van Marck
Journal:  Mod Pathol       Date:  1997-05       Impact factor: 7.842

3.  A novel ETV6-NTRK3 gene fusion in congenital fibrosarcoma.

Authors:  S R Knezevich; D E McFadden; W Tao; J F Lim; P H Sorensen
Journal:  Nat Genet       Date:  1998-02       Impact factor: 38.330

4.  Prognostic impact of bone marrow karyotype in childhood acute lymphoblastic leukaemia: Swedish experiences 1986-91.

Authors:  E Forestier; G Gustafsson; A von Heideman; S Heim; O Hernell; F Mitelman; I Nordenson; B Swolin; S Söderhäll
Journal:  Acta Paediatr       Date:  1997-08       Impact factor: 2.299

Review 5.  The role of cytogenetics in the classification of soft tissue tumours.

Authors:  A P Dei Tos; P Dal Cin
Journal:  Virchows Arch       Date:  1997-08       Impact factor: 4.064

6.  Granulocytic sarcoma with translocation (9;11)(p22;q23): two cases.

Authors:  N P Bown; D Rowe; M M Reid
Journal:  Cancer Genet Cytogenet       Date:  1997-07-15

7.  Elevated serum CD44 level is associated with unfavorable outcome in non-Hodgkin's lymphoma.

Authors:  R Ristamäki; H Joensuu; K Lappalainen; L Teerenhovi; S Jalkanen
Journal:  Blood       Date:  1997-11-15       Impact factor: 22.113

8.  SYT-SSX gene fusion as a determinant of morphology and prognosis in synovial sarcoma.

Authors:  A Kawai; J Woodruff; J H Healey; M F Brennan; C R Antonescu; M Ladanyi
Journal:  N Engl J Med       Date:  1998-01-15       Impact factor: 91.245

9.  Cytogenetic features of infants less than 12 months of age at diagnosis of acute lymphoblastic leukemia: impact of the 11q23 breakpoint on outcome: a report of the Childrens Cancer Group.

Authors:  N A Heerema; D C Arthur; H Sather; V Albo; J Feusner; B J Lange; P G Steinherz; P Zeltzer; D Hammond; G H Reaman
Journal:  Blood       Date:  1994-04-15       Impact factor: 22.113

10.  Increased serum concentration of the soluble interleukin-2 receptor in cutaneous T-cell lymphoma. Clinical and prognostic implications.

Authors:  M A Wasik; E C Vonderheid; R D Bigler; R Marti; S R Lessin; M Polansky; M E Kadin
Journal:  Arch Dermatol       Date:  1996-01
View more
  18 in total

1.  Tumour markers in malignancies. Two isoforms of oestrogen receptor are now known to exist.

Authors:  C Palmieri; S Fishpool; R C Coombes
Journal:  BMJ       Date:  2000-08-05

Review 2.  Demystified... Molecular pathology in oncology.

Authors:  J Crocker
Journal:  Mol Pathol       Date:  2002-12

3.  Genetics 101: polymerase chain reaction.

Authors:  Alison Sinclair
Journal:  CMAJ       Date:  2002-10-29       Impact factor: 8.262

4.  The diagnostic value of alcohol dehydrogenase (ADH) isoenzymes and aldehyde dehydrogenase (ALDH) measurement in the sera of gastric cancer patients.

Authors:  Wojciech Jelski; Karolina Orywal; Magdalena Laniewska; Maciej Szmitkowski
Journal:  Clin Exp Med       Date:  2010-05-09       Impact factor: 3.984

Review 5.  Clinical endpoints in trials of drugs for cancer: time for a rethink?

Authors:  P P Koopmans
Journal:  BMJ       Date:  2002-06-08

6.  Stem cell factor (SCF) and interleukin 3 (IL-3) in the sera of patients with colorectal cancer.

Authors:  Barbara Mroczko; Maciej Szmitkowski; Urszula Wereszczyńska-Siemiatkowska; Bogna Okulczyk
Journal:  Dig Dis Sci       Date:  2005-06       Impact factor: 3.199

7.  Multicolor-FICTION: expanding the possibilities of combined morphologic, immunophenotypic, and genetic single cell analyses.

Authors:  José Ignacio Martín-Subero; Ilse Chudoba; Lana Harder; Stefan Gesk; Werner Grote; Francisco Javier Novo; María José Calasanz; Reiner Siebert
Journal:  Am J Pathol       Date:  2002-08       Impact factor: 4.307

8.  The diagnostic value of alcohol dehydrogenase (ADH) isoenzymes and aldehyde dehydrogenase (ALDH) measurement in the sera of colorectal cancer patients.

Authors:  Wojciech Jelski; Barbara Mroczko; Maciej Szmitkowski
Journal:  Dig Dis Sci       Date:  2010-01-13       Impact factor: 3.199

9.  Levels of v5 and v6 CD44 splice variants in serum of patients with colorectal cancer are not correlated with pT stage, histopathological grade of malignancy and clinical features.

Authors:  Bogdan Zalewski
Journal:  World J Gastroenterol       Date:  2004-02-15       Impact factor: 5.742

10.  Pretreatment serum levels of hematopoietic cytokines in patients with colorectal adenomas and cancer.

Authors:  Barbara Mroczko; Maciej Szmitkowski; Urszula Wereszczyńska-Siemiatkowska; Bogna Okulczyk; Bogusław Kedra
Journal:  Int J Colorectal Dis       Date:  2006-03-07       Impact factor: 2.571
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.